Amoxicillin pharmacokinetics in adults
Pro Research Analysisby 
Searched over 200M research papers
Amoxicillin Pharmacokinetics in Adults: Key Parameters and Influencing Factors
Absorption and Bioavailability of Amoxicillin in Adults
Amoxicillin is well absorbed after oral administration, with nearly complete bioavailability. Studies show that the area under the curve (AUC) for oral amoxicillin is about 93% of that seen with intravenous administration, and urinary recovery is around 86%, indicating efficient absorption through the gastrointestinal tract . However, absorption is dose-dependent and non-linear, with higher doses leading to slower and lower peak serum concentrations due to saturable absorption mechanisms 479. The oral bioavailability of amoxicillin in obese adults is reported to be approximately 80% .
Distribution, Metabolism, and Elimination
Amoxicillin is distributed in the body with a central volume of distribution ranging from about 9 L in obese adults to 27.7 L in healthy volunteers, depending on the population studied 14. Clearance rates also vary, with values such as 14.6 L/h in obese adults and 21.3 L/h in healthy volunteers 14. The elimination half-life of amoxicillin is generally between 1.2 and 1.5 hours, consistent across different populations and dosing regimens 234.
Pharmacokinetics in Special Populations: Obesity and Bariatric Patients
Obese adults and bariatric patients tend to have reduced amoxicillin exposure compared to individuals of normal weight, which may necessitate higher or more frequent dosing to achieve therapeutic targets 18. For example, a regimen of 1 g every 8 hours is recommended for obese adults to ensure adequate drug levels, and liquid formulations are preferred for bariatric patients to optimize absorption . In obese subjects, the maximum concentration (Cmax) after oral administration decreases with increasing body weight .
Dosing Regimens and Clinical Implications
Amoxicillin pharmacokinetics are best described by a two-compartment model with first-order elimination 13. The absorption process is saturable, and higher doses do not proportionally increase peak concentrations or AUC, which has implications for dosing strategies 479. Regimens with lower doses given more frequently (e.g., 500 mg three times daily) are more effective at maintaining drug concentrations above the minimum inhibitory concentration (MIC) compared to high-dose or twice-daily regimens . Extended-release formulations can maintain plasma concentrations above 4 μg/mL for about 49% of the dosing interval, which is beneficial for treating infections caused by less susceptible pathogens 26.
Drug Interactions Affecting Amoxicillin Pharmacokinetics
Co-administration of amoxicillin with other drugs can alter its pharmacokinetics. For example, taking amoxicillin with ranitidine significantly reduces its peak plasma concentration, suggesting that these drugs should be administered at different times to avoid reduced efficacy .
Summary of Key Pharmacokinetic Parameters
- Bioavailability: ~80–93% after oral administration 17
- Half-life: 1.2–1.5 hours 234
- Clearance: 14.6–21.3 L/h (varies by population) 14
- Volume of distribution: 9–27.7 L 14
- Absorption: Non-linear, saturable at higher doses 479
- Cmax: Decreases with increasing dose and body weight 147
Conclusion
Amoxicillin in adults demonstrates high oral bioavailability, rapid elimination, and dose-dependent, non-linear absorption. Obesity and bariatric surgery can reduce drug exposure, requiring adjustments in dosing. Frequent, lower-dose regimens are generally more effective than high-dose, less frequent regimens for maintaining therapeutic drug levels. Drug interactions, such as with ranitidine, can significantly impact amoxicillin pharmacokinetics and should be managed carefully. Overall, understanding these pharmacokinetic properties is essential for optimizing amoxicillin therapy in adult patients.
Sources and full results
Most relevant research papers on this topic
Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints.
The amoxicillin absorption rate is saturable, and high-dose and twice-daily regimens have less favorable pharmacokinetics than lower doses and higher frequency.
Amoxicillin/clavulanic acid 2000mg/125mg extended release (XR): a review of its use in the treatment of respiratory tract infections in adults.
Amoxicillin/clavulanic acid XR is an effective and tolerable treatment for respiratory tract infections in adults, particularly against Streptococcus pneumoniae with reduced susceptibility to amoxicillin.
New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.
New formulations of amoxicillin/clavulanic acid show potential in enhancing antibiotic effectiveness against bacteria, with potential interactions and reduced bioavailability of clavulanic acid.
Oral amoxicillin and amoxicillin-clavulanate: properties, indications, and usage.
Oral amoxicillin is preferred over amoxicillin-clavulanic acid due to its shorter half-life, lower heat stability, and less gastrointestinal side effects.
DOI